Merit Medical Systems Revenue 2006-2021 | MMSI

Merit Medical Systems revenue from 2006 to 2021. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Merit Medical Systems Annual Revenue
(Millions of US $)
2020 $964
2019 $995
2018 $883
2017 $728
2016 $604
2015 $542
2014 $510
2013 $449
2012 $394
2011 $359
2010 $297
2009 $257
2008 $227
2007 $208
2006 $191
2005 $167
Merit Medical Systems Quarterly Revenue
(Millions of US $)
2021-06-30 $280
2021-03-31 $249
2020-12-31 $258
2020-09-30 $244
2020-06-30 $218
2020-03-31 $244
2019-12-31 $258
2019-09-30 $243
2019-06-30 $256
2019-03-31 $238
2018-12-31 $233
2018-09-30 $222
2018-06-30 $225
2018-03-31 $203
2017-12-31 $191
2017-09-30 $179
2017-06-30 $187
2017-03-31 $171
2016-12-31 $158
2016-09-30 $157
2016-06-30 $151
2016-03-31 $138
2015-12-31 $138
2015-09-30 $136
2015-06-30 $138
2015-03-31 $130
2014-12-31 $133
2014-09-30 $129
2014-06-30 $129
2014-03-31 $119
2013-12-31 $120
2013-09-30 $115
2013-06-30 $110
2013-03-31 $104
2012-12-31 $102
2012-09-30 $96
2012-06-30 $101
2012-03-31 $96
2011-12-31 $91
2011-09-30 $90
2011-06-30 $91
2011-03-31 $87
2010-12-31 $81
2010-09-30 $73
2010-06-30 $75
2010-03-31 $67
2009-12-31 $67
2009-09-30 $67
2009-06-30 $65
2009-03-31 $58
2008-12-31 $58
2008-09-30 $58
2008-06-30 $57
2008-03-31 $54
2007-12-31 $54
2007-09-30 $51
2007-06-30 $52
2007-03-31 $51
2006-12-31 $51
2006-09-30 $47
2006-06-30 $48
2006-03-31 $45
2005-12-31 $43
2005-09-30 $41
2005-06-30 $42
2005-03-31 $40
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $4.032B $0.964B
Merit Medical Systems, Inc. set out to build the world's most customer-focused healthcare company by understanding customers' needs, and innovating and delivering a diverse range of products that improve the lives of people, families, and communities throughout the world. Merit's primary products consist of inflation devices used in angioplasty and stent placement; diagnostic and therapeutic catheters used for various procedures in cardiology and radiology; diagnostic and hydrophilic products used to manage and monitor the administration of contrast media and other fluid solutions; thrombolytic catheters and fluid dispensing systems; and embolotherapeutic products for the treatment of uterine fibroids, hypervascularised tumours, and arteriovenous malformations; and procedural trays, packs, and kits.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $75.229B 19.74
Align Technology (ALGN) United States $56.840B 81.93
West Pharmaceutical Services (WST) United States $33.188B 64.09
Straumann Holding AG (SAUHF) Switzerland $32.360B 0.00
McKesson (MCK) United States $32.134B 10.38
Laboratory Of America Holdings (LH) United States $28.528B 8.73
AmerisourceBergen (ABC) United States $25.655B 14.09
Cooper (COO) United States $21.526B 33.28
Cardinal Health (CAH) United States $14.917B 9.47
DENTSPLY SIRONA (XRAY) United States $13.382B 20.62
Henry Schein (HSIC) United States $10.822B 17.69
STAAR Surgical (STAA) United States $6.795B 238.95
CONMED (CNMD) United States $3.792B 42.49
Patterson (PDCO) United States $3.015B 15.34
SmileDirectClub (SDC) United States $2.600B 0.00
Atrion (ATRI) United States $1.332B 42.71
Antares Pharma (ATRS) United States $0.636B 34.00
Retractable Technologies (RVP) United States $0.400B 7.79
Invacare (IVC) United States $0.205B 0.00
Vapor (HCMC) United States $0.204B 0.00
Milestone Scientific (MLSS) United States $0.135B 0.00
Biolase (BIOL) United States $0.104B 0.00
Pro-Dex (PDEX) United States $0.096B 23.57
Lifevantage (LFVN) United States $0.095B 6.86